A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease

Masahiro Jinzaki, Masaharu Hirano, Kazuhiro Hara, Takahiko Suzuki, Akira Yamashina, Yuji Ikari, Misako Iino, Takuhiro Yamaguchi, Sachio Kuribayashi

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint Dive into the research topics of 'A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β<sub>1</sub>-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease'. Together they form a unique fingerprint.

Medicine & Life Sciences